Under construction – not a live service
Sign in
Taking people in FranceNo phase

Home-Based Cognitive Strategy Training for Adults With Chronic Stroke

Tests a home-based thinking-skills training program for daily tasks in adults with chronic stroke.

Plain-language title generated from the registry record
Registry title: Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke

Key facts

Where
Toulouse, FranceSee the site

Where in France

  • University Hospital of ToulouseToulouse, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Toulouse
Trial code
NCT07084025
Record updated
8 May 2026
Original description
This pilot experimental study aims to describe the feasibility of a cognitive strategy training protocol : PRPP-I, in activities of daily life across home-based setting for adults with chronic stroke for improvement of independence and quality of life. Aditionnally to examine preliminary effectiveness of PRPP-I protocol within a home-based setting on functional cognitive strategies, independence, quality of life and career burden.Read full original descriptionShow less

Feasibility of Home-based Cognitive Strategy Training for Independence of Activities of Daily Living in Adults With Chronic Stroke

This pilot experimental study aims to describe the feasibility of a cognitive strategy training protocol : PRPP-I, in activities of daily life across home-based setting for adults with chronic stroke for improvement of independence and quality of life. Aditionnally to examine preliminary effectiveness of PRPP-I protocol within a home-based setting on functional cognitive strategies, independence, quality of life and career burden.

Patient's Main Eligibility criteria:; Adult over 18 years of age; cognitive deficits (or Acquired Brain Injury) diagnosed due to ischemic or hemorrhagic, hemispheric or brainstem stroke, confirmed by brain imaging longer than 6 months; Patient with mild (<26/30 or <25/30 for patients aged 71-85 yr) or moderate ([18-25]/30) cognitive impairment, measured by the Montreal Cognitive Assessment test ; adults living in a home or community-based setting; Patient with a non-professional caregiver; Patient's Main Exclusion criteria; Neurological pathology other than stroke or psychiatric disorder; Significant cognitive impairment, according to MoCA score <18/30; Patient with severe aphasia, Boston Diagnostic Aphasia Examination score >2.

ClinicalTrials.gov NCT07084025